Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
109,272,143
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
887,682
-
Shares change
-
-196,022
-
Total reported value, excl. options
-
$2,434,336
-
Value change
-
-$773,341
-
Number of buys
-
10
-
Number of sells
-
-15
-
Price
-
$2.77
Significant Holders of ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) as of Q2 2021
41 filings reported holding ONCY - ONCOLYTICS BIOTECH INC - Common Stock, no par value as of Q2 2021.
ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 887,682 shares
of 109,272,143 outstanding shares and own 0.81% of the company stock.
Largest 10 shareholders include INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC (161,826 shares), Advisor Resource Council (101,000 shares), TWO SIGMA ADVISERS, LP (91,000 shares), CIBC World Markets Inc. (61,940 shares), TD ASSET MANAGEMENT INC (52,007 shares), BANK OF AMERICA CORP /DE/ (49,310 shares), MORGAN STANLEY (45,678 shares), ROYAL BANK OF CANADA (36,652 shares), Virtu Financial LLC (35,425 shares), and CITADEL ADVISORS LLC (29,389 shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.